These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

417 related items for PubMed ID: 17898346

  • 1. Olanzapine versus placebo in the treatment of adolescents with bipolar mania.
    Tohen M, Kryzhanovskaya L, Carlson G, Delbello M, Wozniak J, Kowatch R, Wagner K, Findling R, Lin D, Robertson-Plouch C, Xu W, Dittmann RW, Biederman J.
    Am J Psychiatry; 2007 Oct; 164(10):1547-56. PubMed ID: 17898346
    [Abstract] [Full Text] [Related]

  • 2. Olanzapine-divalproex combination versus divalproex monotherapy in the treatment of bipolar mixed episodes: a double-blind, placebo-controlled study.
    Houston JP, Tohen M, Degenhardt EK, Jamal HH, Liu LL, Ketter TA.
    J Clin Psychiatry; 2009 Nov; 70(11):1540-7. PubMed ID: 19778495
    [Abstract] [Full Text] [Related]

  • 3. Olanzapine versus lithium in the acute treatment of bipolar mania: a double-blind, randomized, controlled trial.
    Niufan G, Tohen M, Qiuqing A, Fude Y, Pope E, McElroy H, Ming L, Gaohua W, Xinbao Z, Huichun L, Liang S.
    J Affect Disord; 2008 Jan; 105(1-3):101-8. PubMed ID: 17531327
    [Abstract] [Full Text] [Related]

  • 4. Randomized, placebo-controlled trial of olanzapine as maintenance therapy in patients with bipolar I disorder responding to acute treatment with olanzapine.
    Tohen M, Calabrese JR, Sachs GS, Banov MD, Detke HC, Risser R, Baker RW, Chou JC, Bowden CL.
    Am J Psychiatry; 2006 Feb; 163(2):247-56. PubMed ID: 16449478
    [Abstract] [Full Text] [Related]

  • 5. Olanzapine versus divalproex versus placebo in the treatment of mild to moderate mania: a randomized, 12-week, double-blind study.
    Tohen M, Vieta E, Goodwin GM, Sun B, Amsterdam JD, Banov M, Shekhar A, Aaronson ST, Bardenstein L, Grecu-Gabos I, Tochilov V, Prelipceanu D, Oliff HS, Kryzhanovskaya L, Bowden C.
    J Clin Psychiatry; 2008 Nov; 69(11):1776-89. PubMed ID: 19014751
    [Abstract] [Full Text] [Related]

  • 6. Safety and efficacy of olanzapine monotherapy and olanzapine with a mood stabilizer in 18-week treatment of manic/mixed episodes for Japanese patients with bipolar I disorder.
    Katagiri H, Takita Y, Tohen M, Higuchi T, Kanba S, Takahashi M.
    Curr Med Res Opin; 2012 May; 28(5):701-13. PubMed ID: 22356118
    [Abstract] [Full Text] [Related]

  • 7. Olanzapine versus placebo in adolescents with schizophrenia: a 6-week, randomized, double-blind, placebo-controlled trial.
    Kryzhanovskaya L, Schulz SC, McDougle C, Frazier J, Dittmann R, Robertson-Plouch C, Bauer T, Xu W, Wang W, Carlson J, Tohen M.
    J Am Acad Child Adolesc Psychiatry; 2009 Jan; 48(1):60-70. PubMed ID: 19057413
    [Abstract] [Full Text] [Related]

  • 8. Olanzapine versus placebo in the treatment of acute mania. Olanzapine HGEH Study Group.
    Tohen M, Sanger TM, McElroy SL, Tollefson GD, Chengappa KN, Daniel DG, Petty F, Centorrino F, Wang R, Grundy SL, Greaney MG, Jacobs TG, David SR, Toma V.
    Am J Psychiatry; 1999 May; 156(5):702-9. PubMed ID: 10327902
    [Abstract] [Full Text] [Related]

  • 9. Olanzapine/Fluoxetine combination in children and adolescents with bipolar I depression: a randomized, double-blind, placebo-controlled trial.
    Detke HC, DelBello MP, Landry J, Usher RW.
    J Am Acad Child Adolesc Psychiatry; 2015 Mar; 54(3):217-24. PubMed ID: 25721187
    [Abstract] [Full Text] [Related]

  • 10. Efficacy of olanzapine in acute bipolar mania: a double-blind, placebo-controlled study. The Olanzipine HGGW Study Group.
    Tohen M, Jacobs TG, Grundy SL, McElroy SL, Banov MC, Janicak PG, Sanger T, Risser R, Zhang F, Toma V, Francis J, Tollefson GD, Breier A.
    Arch Gen Psychiatry; 2000 Sep; 57(9):841-9. PubMed ID: 10986547
    [Abstract] [Full Text] [Related]

  • 11. Efficacy and safety of olanzapine for treatment of patients with bipolar depression: Japanese subpopulation analysis of a randomized, double-blind, placebo-controlled study.
    Katagiri H, Tohen M, McDonnell DP, Fujikoshi S, Case M, Kanba S, Takahashi M, Gomez JC.
    BMC Psychiatry; 2013 May 14; 13():138. PubMed ID: 23672672
    [Abstract] [Full Text] [Related]

  • 12. Olanzapine/fluoxetine combination for the treatment of mixed depression in bipolar I disorder: a post hoc analysis.
    Benazzi F, Berk M, Frye MA, Wang W, Barraco A, Tohen M.
    J Clin Psychiatry; 2009 Oct 14; 70(10):1424-31. PubMed ID: 19906346
    [Abstract] [Full Text] [Related]

  • 13. Olanzapine versus lithium in the maintenance treatment of bipolar disorder: a 12-month, randomized, double-blind, controlled clinical trial.
    Tohen M, Greil W, Calabrese JR, Sachs GS, Yatham LN, Oerlinghausen BM, Koukopoulos A, Cassano GB, Grunze H, Licht RW, Dell'Osso L, Evans AR, Risser R, Baker RW, Crane H, Dossenbach MR, Bowden CL.
    Am J Psychiatry; 2005 Jul 14; 162(7):1281-90. PubMed ID: 15994710
    [Abstract] [Full Text] [Related]

  • 14. A 52-Week Study of Olanzapine with a Randomized Behavioral Weight Counseling Intervention in Adolescents with Schizophrenia or Bipolar I Disorder.
    Detke HC, DelBello MP, Landry J, Hoffmann VP, Heinloth A, Dittmann RW.
    J Child Adolesc Psychopharmacol; 2016 Dec 14; 26(10):922-934. PubMed ID: 27676420
    [Abstract] [Full Text] [Related]

  • 15. Olanzapine versus divalproex in the treatment of acute mania.
    Tohen M, Baker RW, Altshuler LL, Zarate CA, Suppes T, Ketter TA, Milton DR, Risser R, Gilmore JA, Breier A, Tollefson GA.
    Am J Psychiatry; 2002 Jun 14; 159(6):1011-7. PubMed ID: 12042191
    [Abstract] [Full Text] [Related]

  • 16. Olanzapine versus divalproex sodium for the treatment of acute mania and maintenance of remission: a 47-week study.
    Tohen M, Ketter TA, Zarate CA, Suppes T, Frye M, Altshuler L, Zajecka J, Schuh LM, Risser RC, Brown E, Baker RW.
    Am J Psychiatry; 2003 Jul 14; 160(7):1263-71. PubMed ID: 12832240
    [Abstract] [Full Text] [Related]

  • 17. Olanzapine versus risperidone in the treatment of manic or mixed States in bipolar I disorder: a randomized, double-blind trial.
    Perlis RH, Baker RW, Zarate CA, Brown EB, Schuh LM, Jamal HH, Tohen M.
    J Clin Psychiatry; 2006 Nov 14; 67(11):1747-53. PubMed ID: 17196055
    [Abstract] [Full Text] [Related]

  • 18. Comparison of long-term (at least 24 weeks) weight gain and metabolic changes between adolescents and adults treated with olanzapine.
    Kryzhanovskaya LA, Xu W, Millen BA, Acharya N, Jen KY, Osuntokun O.
    J Child Adolesc Psychopharmacol; 2012 Apr 14; 22(2):157-65. PubMed ID: 22372514
    [Abstract] [Full Text] [Related]

  • 19. The antidepressant effects of risperidone and olanzapine in bipolar disorder.
    McIntyre RS, Mancini DA, Srinivasan J, McCann S, Konarski JZ, Kennedy SH.
    Can J Clin Pharmacol; 2004 Apr 14; 11(2):e218-26. PubMed ID: 15520475
    [Abstract] [Full Text] [Related]

  • 20. Weight gain during treatment of bipolar I patients with olanzapine.
    Hennen J, Perlis RH, Sachs G, Tohen M, Baldessarini RJ.
    J Clin Psychiatry; 2004 Dec 14; 65(12):1679-87. PubMed ID: 15641874
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.